HomeCBI • TLV
add
Clal Biotechnology Industries Ltd.
Previous close
ILA 33.90
Day range
ILA 33.10 - ILA 34.00
Year range
ILA 28.20 - ILA 53.00
Market cap
51.92M ILS
Avg Volume
66.26K
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
(ILS) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.52M | -33.54% |
Net income | -10.60M | 36.69% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.38M | -164.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(ILS) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 5.01M | -62.48% |
Total assets | 67.69M | -57.26% |
Total liabilities | 21.52M | -41.80% |
Total equity | 46.16M | — |
Shares outstanding | 156.85M | — |
Price to book | 1.47 | — |
Return on assets | -5.60% | — |
Return on capital | -5.66% | — |
Cash Flow
Net change in cash
(ILS) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -10.60M | 36.69% |
Cash from operations | -1.64M | 32.35% |
Cash from investing | 1.73M | 1,593.63% |
Cash from financing | -1.48M | -1,727.16% |
Net change in cash | -1.39M | 41.87% |
Free cash flow | -942.75K | 40.80% |
About
Founded
1998
Website
Employees
3